definiens: shall mean th < e ficJd 0 . [ diagnosing, predicting and monitoring of cardiac risk utilizing systems that are approved by the : app1icahle governmenta.l regulatory : mthoritjes for use by jndividual~ WitllOul supervision by a licensed medical practitioner and thal are directly marketed to puhlic consumers in as : oociation or combination \vith a nutraceutical . vitamiu, nutritional supplement, he : alth food or similar product ; 1,9.3 ' shall mean the field of diagnosing, predicting and monitoring of cardiac risk utibzing sy ~ tem & ~hat are approved by the applicabLe govcmmC1lt ~ l regulatory authorities for use under the : supervision of trained medic~11 personnel and/or trained healthcare workers mId that arc operaled in an outpatient clinic, medical laboratory, patient collection center associated with a laboratory, hospital laboratory or similar venue providing labt)tatory services~ L 9.4 shall mean the field of diagnosing, prcdictit1 g and monitoring of cardiac risk utilizing systems that are approved by the applicable governmental regulatory authorities for use uuder lhe ~lIpervig~(}n of a licensed medical practitioner, other than the Laboratory Field, as described above : 1 - 9.5 shaH mean the field of diagnosing " predicting and monitoring of cardiac risk utilizing SystC1l1S that arc approved by Ihe tlppljcahl~ government-'ll regnia.t()ry authorities fOf use in all fields oth (, ' ! 1h81 ) lhe Consu : rner, NutraceuticaL Laboralory and Professional F ie1ds